Abstract:Schistosomiasis is a fatal zoonotic parasitic disease that also threatens human health. The main pathological features of schistosomiasis are granulomatous inflammation and subsequent liver fibrosis, which is a complex, chronic, and progressive disease. Extracellular vesicles (EVs) derived from schistosome eggs are broadly involved in host-parasite communication and act as important contributors to schistosome-induced liver fibrosis. However, it remains unclear whether substances secreted by the EVs of Schistosoma japonicum , a long-term parasitic "partner" in the hepatic portal vein of the host, also participate in liver fibrosis. Here, we report that EVs derived from S . japonicum worms attenuated liver fibrosis by delivering sja-let-7 into hepatic stellate cells (HSCs). Mechanistically, activation of HSCs was reduced by targeting collagen type I alpha 2 chain (Col1α2) and downregulation of the TGF-β/Smad signaling pathway both in vivo and in vitro . Overall, these results contribute to further understanding of the molecular mechanisms underlying host-parasite interactions and identified the sja-let-7/Col1α2/TGF-β/Smad axis as a potential target for treatment of schistosomiasis-related liver fibrosis. Schistosomiasis is a neglected parasitic disease that affects over 250 million people in tropical and subtropical regions worldwide. As common pathogenic species, the eggs of Schistosoma japonicum and S . mansoni cause hepatic schistosomiasis, which can lead to granulomatous inflammation and subsequent liver fibrosis. Hence, elucidation of the mechanisms underlying liver fibrosis and host-parasite crosstalk is essential to inhibiting the progression of schistosomiasis. Accumulating evidence supports the pivotal role of schistosome egg-derived extracellular vesicles (EVs) in the onset and progression of schistosomiasis. However, the potential involvement of schistosome worm-derived EVs in the activation and modulation of hepatic stellate cells (HSCs) in hepatic schistosomiasis remains largely unknown. The results of this study demonstrate that the release of sja-let-7 by S . japonicum worm-derived EVs reduced activation of HSCs by targeting Col1α2 and further attenuated the progression of liver fibrosis by mediating the TGF-β/Smad signaling pathway. These findings provide evidence for the application of worm-derived substances and the sja-let-7/Col1α2/TGF-β/Smad axis as a novel therapeutic target for treatment of liver fibrosis.

[Pathology and Pathogenesis of Liver Fibrosis Induced by Schistosoma Japonicum].

[Re-Understanding of Liver Cirrhosis Induced by Schistosomiasis Japonica].

Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis

T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis

Research Advances in Pathogenesis of Schistosomiasis Hepatic Fibrosis

Lipid Metabolism Regulate the Inflammatory Microenvironment in the Hepatic Fibrosis Induced by Schistosoma Japonicum Infection in China: A Genotype-Phenotype Association Study

Pathological Changes in Hepatic Sinusoidal Endothelial Cells in Schistosoma japonicum-Infected Mice

The Dynamics of Hepatic Fibrosis Related to Schistosomiasis and Its Risk Factors in a Cohort of China

Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis

Effect of hepatocyte damage in hepatic fibrogenesis of patients infected with Schistosoma japonicum

Single-cell RNA sequencing to dissect the immunological network of liver fibrosis in Schistosoma japonicum-infected mice

Longitudinal Immune Profiling Highlights CD4+ T Cell Exhaustion Correlated with Liver Fibrosis in Schistosoma japonicum Infection

Hepatic schistosomiasis as a determining factor in the development of hepatic granulomas and liver fibrosis: a review of the current literature

Activation of Primary Hepatic Stellate Cells and Liver Fibrosis Induced by Targeting TGF-β1/Smad Signaling in Schistosomiasis in Mice

Single-Cell Analysis Reveals the Cellular and Molecular Changes of Liver Injury and Fibrosis in Mice During the Progression of Schistosoma japonicum Infection

Galectin-receptor interaction: a key player in liver fibrosis induced by Schistosoma japonicum infection

Sja-let-7 suppresses the development of liver fibrosis via Schistosoma japonicum extracellular vesicles

Dysregulated Glucuronidation of Bilirubin Exacerbates Liver Inflammation and Fibrosis in Schistosomiasis Japonica through the NF-κB Signaling Pathway

Hepatic Stellate Cells and Schistosomiasis Liver Fibrosis

Advances in the study of the interaction between schistosome infections and the host's intestinal microorganisms

Cytokine regulation of schistosome-induced granuloma and fibrosis